<?xml version="1.0" encoding="UTF-8"?>
<p>The vaccine efficacy of A (H1N1) pdm09 was predicted using the P
 <sub>epitope</sub> model [
 <xref rid="pone.0228029.ref020" ref-type="bibr">20</xref>, 
 <xref rid="pone.0228029.ref027" ref-type="bibr">27</xref>]. P
 <sub>epitope</sub> is expressed as a ratio of amino acid changes in the dominant HA epitope between the vaccine strain and circulating virus [
 <xref rid="pone.0228029.ref026" ref-type="bibr">26</xref>, 
 <xref rid="pone.0228029.ref027" ref-type="bibr">27</xref>]. It is computed by dividing the number of amino acid changes in the HA epitope by the total number of amino acids in the epitope) [
 <xref rid="pone.0228029.ref016" ref-type="bibr">16</xref>, 
 <xref rid="pone.0228029.ref026" ref-type="bibr">26</xref>, 
 <xref rid="pone.0228029.ref027" ref-type="bibr">27</xref>]. An epitope with the highest substitutions (antigenic distance) is considered dominant [
 <xref rid="pone.0228029.ref020" ref-type="bibr">20</xref>, 
 <xref rid="pone.0228029.ref027" ref-type="bibr">27</xref>]. The epitope regions of A (H1N1) pdm09 isolates analyzed in this study were predicted using H3 numbering as previously described [
 <xref rid="pone.0228029.ref002" ref-type="bibr">2</xref>, 
 <xref rid="pone.0228029.ref020" ref-type="bibr">20</xref>]. The vaccine efficacy was calculated by E = (0.47â€“2.47 x P
 <sub>epitope</sub>) x 100 [
 <xref rid="pone.0228029.ref002" ref-type="bibr">2</xref>, 
 <xref rid="pone.0228029.ref020" ref-type="bibr">20</xref>, 
 <xref rid="pone.0228029.ref027" ref-type="bibr">27</xref>].
</p>
